Innovations (1):

• Treatment of HIV-1 By Modulation of VPR Activation of the M-CSF Promoter

Selected Publications (5):

• 2009. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. The Journal of biological chemistry 284(17):11364-73.
• 2008. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. Journal of neurovirology 14(4):318-26.
• Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat. Anticancer research 28(3A):1441-7.
• 2008. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS research and human retroviruses 24(3):417-21.
• 2008. Regulation of complement component C3 in astrocytes by IL-1beta and mor Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 3(1):.